Aehr Test Systems Stock Soars on Earnings, Eyes Over 150% Revenue Growth

Summary

Aehr Test Systems TodayAEHRAehr Test Systems$84.38 +0.18 (+0.21%) As of 12:17 PM Eastern This is a fair market value price provided by Massive. Learn more.52-Week Range$14.99▼$126.62Price Target$117.50 As AI stocks swing up and down, one name that has felt those movements as much as any is Aehr Test Systems NASDAQ: AEHR. This small stock has risen about 320% in 2026, and sits at a market capitalization of $2.7 billion in mid-July. Though shares have been in a downtrend over the past 30 days, they saw a huge rebound after Aehr posted its latest earnings report, spiking nearly 22% in a single day.Get Aehr Test Systems alerts:Sign Up Aehr’s large move came as it surpassed estimates during the quarter and issued inspiring guidance. This guidance meaningfully changes how investors should view Aehr’s valuation and increases confidence in its outlook. Aehr’s Revenue Rises Over 30%, Gross Margin Explodes UpwardAehr makes machines that put semiconductors under intense conditions, testing them for defects. As data center operators look to increase performance by weeding out faulty chips, Aehr has been gaining considerable order momentum. In Q4 of its fiscal year 2026 (FY2026), Aehr posted revenue of $18.84 million. (Note that Aehr’s fiscal reporting period is several quarters ahead of the calendar year period.) This resulted in growth of 33.7% year-over-year (YOY). Notably, this marks the first time in over a year that Aehr’s quarterly revenue growth was positive, an important inflection for its business. However, analysts expected this performance, with Aehr just slightly beating estimates of $18.69 million. Alongside this, Aehr crushed estimates on earnings per share (EPS). The figure came in at 11 cents, swinging strongly from -1 cent a year ago. Analysts anticipated that EPS would remain unchanged at -1 cents. This came as Aehr greatly outperformed on adjusted gross margin, which soared 1,000 basis points to 45%, driven by higher sales, improved manufacturing capacity uti...